Copyright Reports & Markets. All rights reserved.

Global Psoriatic Arthritis Therapeutics Drug Market Opportunities and Forecast 2022-2028

Request for Sample of this report
Buy now

Table of Contents

    1 Product Introduction and Overview

    • 1.1 Product Definition
    • 1.2 Product Specification
    • 1.3 Global Market Overview
      • 1.3.1 Global Psoriatic Arthritis Therapeutics Drug Market Status and Forecast (2017-2028)
      • 1.3.2 Global Psoriatic Arthritis Therapeutics Drug Sales Value CAGR by Region
    • 1.4 Market Drivers, Inhibitors
      • 1.4.1 Market Drivers
      • 1.4.2 Market Inhibitors
      • 1.4.3 COVID-19 Impact Analysis

    2 Global Psoriatic Arthritis Therapeutics Drug Supply by Company

    • 2.1 Global Psoriatic Arthritis Therapeutics Drug Sales Volume by Company
    • 2.2 Global Psoriatic Arthritis Therapeutics Drug Sales Value by Company
    • 2.3 Global Psoriatic Arthritis Therapeutics Drug Price by Company
    • 2.4 Psoriatic Arthritis Therapeutics Drug Production Location and Sales Area of Main Manufacturers
    • 2.5 Trend of Concentration Rate

    3 Global and Regional Psoriatic Arthritis Therapeutics Drug Market Status by Type

    • 3.1 Psoriatic Arthritis Therapeutics Drug Type Introduction
      • 3.1.1 NF Inhibitors
      • 3.1.2 Interleukin Inhibitors
      • 3.1.3 PDE4 Inhibitors
      • 3.1.4 Others
    • 3.2 Global Psoriatic Arthritis Therapeutics Drug Market by Type
      • 3.2.1 Global Psoriatic Arthritis Therapeutics Drug Sales Volume by Type (2017-2022)
      • 3.2.2 Global Psoriatic Arthritis Therapeutics Drug Sales Value by Type (2017-2022)
      • 3.2.3 Global Psoriatic Arthritis Therapeutics Drug Price by Type (2017-2022)
    • 3.3 North America: by Type
    • 3.4 Europe: by Type
    • 3.5 Asia Pacific: by Type
    • 3.6 Central & South America: by Type
    • 3.7 Middle East & Africa: by Type

    4 Global and Regional Psoriatic Arthritis Therapeutics Drug Market Status by Application

    • 4.1 Psoriatic Arthritis Therapeutics Drug Segment by Application
      • 4.1.1 Hospital Pharmacies
      • 4.1.2 Retail Pharmacies
      • 4.1.3 Online Pharmacies
    • 4.2 Global Psoriatic Arthritis Therapeutics Drug Market by Application
      • 4.2.1 Global Psoriatic Arthritis Therapeutics Drug Sales Volume by Application (2017-2022)
      • 4.2.2 Global Psoriatic Arthritis Therapeutics Drug Sales Value by Application (2017-2022)
      • 4.2.3 Global Psoriatic Arthritis Therapeutics Drug Price by Application (2017-2022)
    • 4.3 North America: by Application
    • 4.4 Europe: by Application
    • 4.5 Asia Pacific: by Application
    • 4.6 Central & South America: by Application
    • 4.7 Middle East & Africa: by Application

    5 Global Psoriatic Arthritis Therapeutics Drug Market Status by Region

    • 5.1 Global Psoriatic Arthritis Therapeutics Drug Market by Region
      • 5.1.1 Global Psoriatic Arthritis Therapeutics Drug Sales Volume by Region
      • 5.1.2 Global Psoriatic Arthritis Therapeutics Drug Sales Value by Region
    • 5.2 North America Psoriatic Arthritis Therapeutics Drug Market Status
    • 5.3 Europe Psoriatic Arthritis Therapeutics Drug Market Status
    • 5.4 Asia Pacific Psoriatic Arthritis Therapeutics Drug Market Status
    • 5.5 Central & South America Psoriatic Arthritis Therapeutics Drug Market Status
    • 5.6 Middle East & Africa Psoriatic Arthritis Therapeutics Drug Market Status

    6 North America Psoriatic Arthritis Therapeutics Drug Market Status

    • 6.1 North America Psoriatic Arthritis Therapeutics Drug Market by Country
      • 6.1.1 North America Psoriatic Arthritis Therapeutics Drug Sales Volume by Country (2017-2022)
      • 6.1.2 North America Psoriatic Arthritis Therapeutics Drug Sales Value by Country (2017-2022)
    • 6.2 United States
    • 6.3 Canada
    • 6.4 Mexico

    7 Europe Psoriatic Arthritis Therapeutics Drug Market Status

    • 7.1 Europe Psoriatic Arthritis Therapeutics Drug Market by Country
      • 7.1.1 Europe Psoriatic Arthritis Therapeutics Drug Sales Volume by Country (2017-2022)
      • 7.1.2 Europe Psoriatic Arthritis Therapeutics Drug Sales Value by Country (2017-2022)
    • 7.2 Germany
    • 7.3 France
    • 7.4 UK
    • 7.5 Italy
    • 7.6 Russia
    • 7.7 Spain

    8 Asia Pacific Psoriatic Arthritis Therapeutics Drug Market Status

    • 8.1 Asia Pacific Psoriatic Arthritis Therapeutics Drug Market by Country
      • 8.1.1 Asia Pacific Psoriatic Arthritis Therapeutics Drug Sales Volume by Country (2017-2022)
      • 8.1.2 Asia Pacific Psoriatic Arthritis Therapeutics Drug Sales Value by Country (2017-2022)
    • 8.2 China
    • 8.3 Japan
    • 8.4 Korea
    • 8.5 Southeast Asia
    • 8.6 India
    • 8.7 Australasia

    9 Central & South America Psoriatic Arthritis Therapeutics Drug Market Status

    • 9.1 Central & South America Psoriatic Arthritis Therapeutics Drug Market by Country
      • 9.1.1 Central & South America Psoriatic Arthritis Therapeutics Drug Sales Volume by Country (2017-2022)
      • 9.1.2 Central & South America Psoriatic Arthritis Therapeutics Drug Sales Value by Country (2017-2022)
    • 9.2 Brazil
    • 9.3 Argentina
    • 9.4 Colombia

    10 Middle East & Africa Psoriatic Arthritis Therapeutics Drug Market Status

    • 10.1 Middle East & Africa Psoriatic Arthritis Therapeutics Drug Market by Country
      • 10.1.1 Middle East & Africa Psoriatic Arthritis Therapeutics Drug Sales Volume by Country (2017-2022)
      • 10.1.2 Middle East & Africa Psoriatic Arthritis Therapeutics Drug Sales Value by Country (2017-2022)
    • 10.2 Iran
    • 10.3 Israel
    • 10.4 Turkey
    • 10.5 South Africa
    • 10.8 Saudi Arabia

    11 Supply Chain and Manufacturing Cost Analysis

    • 11.1 Supply Chain Analysis
    • 11.2 Production Process Chart Analysis
    • 11.3 Raw Materials and Key Suppliers Analysis
      • 11.3.1 Raw Materials Introduction
      • 11.3.2 Raw Materials Key Suppliers List
    • 11.4 Psoriatic Arthritis Therapeutics Drug Manufacturing Cost Analysis
    • 11.5 Psoriatic Arthritis Therapeutics Drug Sales Channel and Distributors Analysis
      • 11.5.1 Psoriatic Arthritis Therapeutics Drug Sales Channel
      • 11.5.2 Psoriatic Arthritis Therapeutics Drug Distributors
    • 11.6 Psoriatic Arthritis Therapeutics Drug Downstream Major Buyers

    12 Global Psoriatic Arthritis Therapeutics Drug Market Forecast by Type and by Application

    • 12.1 Global Psoriatic Arthritis Therapeutics Drug Sales Volume and Sales Value Forecast (2023-2028)
    • 12.2 Global Psoriatic Arthritis Therapeutics Drug Forecast by Type
      • 12.2.1 Global Psoriatic Arthritis Therapeutics Drug Sales Volume Forecast by Type
      • 12.2.2 Global Psoriatic Arthritis Therapeutics Drug Sales Value Forecast by Type
      • 12.2.3 Global Psoriatic Arthritis Therapeutics Drug Price Forecast by Type
    • 12.3 Global Psoriatic Arthritis Therapeutics Drug Forecast by Application
      • 12.3.1 Global Psoriatic Arthritis Therapeutics Drug Sales Volume Forecast by Application
      • 12.3.2 Global Psoriatic Arthritis Therapeutics Drug Sales Value Forecast by Application
      • 12.3.3 Global Psoriatic Arthritis Therapeutics Drug Price Forecast by Application

    13 Global Psoriatic Arthritis Therapeutics Drug Market Forecast by Region/Country

    • 13.1 Global Psoriatic Arthritis Therapeutics Drug Market Forecast by Region (2023-2028)
      • 13.1.1 Global Psoriatic Arthritis Therapeutics Drug Sales Volume Forecast by Region (2023-2028)
      • 13.1.2 Global Psoriatic Arthritis Therapeutics Drug Sales Value Forecast by Region (2023-2028)
    • 13.2 North America Market Forecast
    • 13.3 Europe Market Forecast
    • 13.4 Asia Pacific Market Forecast
    • 13.5 Central & South America Market Forecast
    • 13.6 Middle East & Africa Market Forecast

    14 Key Participants Company Information

    • 14.1 UCB
      • 14.1.1 Company Information
      • 14.1.2 Psoriatic Arthritis Therapeutics Drug Product Introduction
      • 14.1.3 UCB Psoriatic Arthritis Therapeutics Drug Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
      • 14.1.4 SWOT Analysis
    • 14.2 Pfizer
      • 14.2.1 Company Information
      • 14.2.2 Psoriatic Arthritis Therapeutics Drug Product Introduction
      • 14.2.3 Pfizer Psoriatic Arthritis Therapeutics Drug Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
      • 14.2.4 SWOT Analysis
    • 14.3 Novartis
      • 14.3.1 Company Information
      • 14.3.2 Psoriatic Arthritis Therapeutics Drug Product Introduction
      • 14.3.3 Novartis Psoriatic Arthritis Therapeutics Drug Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
      • 14.3.4 SWOT Analysis
    • 14.4 Janssen Biotech
      • 14.4.1 Company Information
      • 14.4.2 Psoriatic Arthritis Therapeutics Drug Product Introduction
      • 14.4.3 Janssen Biotech Psoriatic Arthritis Therapeutics Drug Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
      • 14.4.4 SWOT Analysis
    • 14.5 Eli Lilly
      • 14.5.1 Company Information
      • 14.5.2 Psoriatic Arthritis Therapeutics Drug Product Introduction
      • 14.5.3 Eli Lilly Psoriatic Arthritis Therapeutics Drug Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
      • 14.5.4 SWOT Analysis
    • 14.6 CELGENE CORPORATION
      • 14.6.1 Company Information
      • 14.6.2 Psoriatic Arthritis Therapeutics Drug Product Introduction
      • 14.6.3 CELGENE CORPORATION Psoriatic Arthritis Therapeutics Drug Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
      • 14.6.4 SWOT Analysis
    • 14.7 Bristol-Myers Squibb
      • 14.7.1 Company Information
      • 14.7.2 Psoriatic Arthritis Therapeutics Drug Product Introduction
      • 14.7.3 Bristol-Myers Squibb Psoriatic Arthritis Therapeutics Drug Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
      • 14.7.4 SWOT Analysis
    • 14.8 Biogen
      • 14.8.1 Company Information
      • 14.8.2 Psoriatic Arthritis Therapeutics Drug Product Introduction
      • 14.8.3 Biogen Psoriatic Arthritis Therapeutics Drug Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
      • 14.8.4 SWOT Analysis
    • 14.9 Amgen
      • 14.9.1 Company Information
      • 14.9.2 Psoriatic Arthritis Therapeutics Drug Product Introduction
      • 14.9.3 Amgen Psoriatic Arthritis Therapeutics Drug Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
      • 14.9.4 SWOT Analysis
    • 14.10 AbbVie
      • 14.10.1 Company Information
      • 14.10.2 Psoriatic Arthritis Therapeutics Drug Product Introduction
      • 14.10.3 AbbVie Psoriatic Arthritis Therapeutics Drug Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
      • 14.10.4 SWOT Analysis

    15 Conclusion

      16 Methodology

      This report provides a comprehensive analysis of current global Psoriatic Arthritis Therapeutics Drug market based on segmented types and downstream applications. Major product development trends are discussed under major downstream segment scenario. This report also focuses on major driving factors and inhibitors that affect the market and competitive landscape. Global and regional leading players in the Psoriatic Arthritis Therapeutics Drug industry are profiled in a detailed way, with sales data and market share info. This report also includes global and regional market size and forecast, drill-down to top 20 economies.

      According to GRD Survey, the global Psoriatic Arthritis Therapeutics Drug market is estimated at $ million in 2021, and projected to grow at a CAGR of % to $ million by 2028.

      Covid-19 pandemic has impacted the supply and demand status for many industries along the supply chain. Global Psoriatic Arthritis Therapeutics Drug Market Opportunties and Forecast 2022-2028 report makes a brilliant attempt to unveil key opportunities available in the global Psoriatic Arthritis Therapeutics Drug market under the covid-19 impact to help readers in achieving a better market position. No matter the client is industry insider, potential entrant or investor, the report will provide useful data and information.

      The Global Psoriatic Arthritis Therapeutics Drug Market has been exhibited in detail in the following chapters
      Chapter 1 displays the basic product introduction and market overview.
      Chapter 2 provides the competition landscape of global Psoriatic Arthritis Therapeutics Drug industry.
      Chapter 3 provides the market analysis by type and by region
      Chapter 4 provides the market analysis by application and by region
      Chapter 5-10 presents regional and country market size and forecast, under the context of market drivers and inhibitors analysis.
      Chapter 11 analyses the supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis.
      Chapter 12 provides the market forecast by type and by application
      Chapter 13 provides the market forecast by region
      Chapter 14 profiles global leading players with their revenue, market share, profit margin, major product portfolio and SWOT analysis.
      Chapter 15 conclusions

      Segmented by Type
      NF Inhibitors
      Interleukin Inhibitors

      Segmented by Application
      Hospital Pharmacies
      Retail Pharmacies
      Online Pharmacies

      Segmented by Country
      North America
      United States
      Canada
      Mexico
      Europe
      Germany
      France
      UK
      Italy
      Russia
      Spain
      Asia Pacific
      China
      Japan
      Korea
      Southeast Asia
      India
      Australasia
      Central & South America
      Brazil
      Argentina
      Colombia
      Middle East & Africa
      Iran
      Israel
      Turkey
      South Africa
      Saudi Arabia

      Key manufacturers included in this survey
      Novartis
      Janssen Biotech
      Eli Lilly
      CELGENE CORPORATION
      Bristol-Myers Squibb
      Biogen
      Amgen
      AbbVie
      Buy now